Amarin Corporation plc - American Depositary Shares (NQ:AMRN)

12.10 +0.01 (+0.08%)

Delayed Quote Updated: 10:01 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amarin Corporation plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 06, 2024

From Amarin Corporation plc

Via GlobeNewswire

AMRN Stock Earnings: Amarin Corp Beats EPS, Misses Revenue for Q1 2024 ↗

May 01, 2024

AMRN stock results show that Amarin Corp beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

Amarin Plc (AMRN) Q1 2024 Earnings Call Transcript ↗

May 01, 2024

AMRN earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

Amarin Reports First Quarter 2024 Business Update and Financial Results

May 01, 2024

From Amarin Corporation plc

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 24, 2024

Via Benzinga

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Why Amarin Stock Skyrocketed Today ↗

January 10, 2024

The biopharma company announced a big repurchase plan, along with strong preliminary Q4 results.

Via The Motley Fool

Why Pharma Company Amarin Shares Are Zooming Today ↗

January 10, 2024

Amarin Corp PLC (NASDAQ: AMRN) shares are trading by around 28% after the company reported

Via Benzinga

Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event

April 24, 2024

Citizen Petition Spotlights Risks for Patients on Drug Proven to Have No Benefit in Improving Cardiovascular Outcomes and Need for Urgent Regulatory Action to Protect Patients

From Amarin Corporation plc

Via GlobeNewswire

Amarin Announces Results of Annual General Meeting of Shareholders

April 22, 2024

- Shareholders Approve Share Repurchase Program of up to $50 Million -

From Amarin Corporation plc

Via GlobeNewswire

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

April 15, 2024

From Amarin Corporation plc

Via GlobeNewswire

Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24

April 08, 2024

Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanism of Action

From Amarin Corporation plc

Via GlobeNewswire

New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

April 06, 2024

From Amarin Corporation plc

Via GlobeNewswire

Why Amarin Stock Was Rocketing Higher on Wednesday ↗

April 03, 2024

There was unambigously good news about the company's single commercialized medication.

Via The Motley Fool

Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe

April 03, 2024

Company’s IP Protection for VAZKEPA® in Europe Now Extended Into 2039

From Amarin Corporation plc

Via GlobeNewswire

Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo

March 25, 2024

From Amarin Corporation plc

Via GlobeNewswire

Amarin Plc (AMRN) Q4 2023 Earnings Call Transcript ↗

February 29, 2024

AMRN earnings call for the period ending December 31, 2023.

Via The Motley Fool

Topics Earnings

Why Is Amarin Stock Trading Lower After Q4 Earnings? ↗

February 29, 2024

Amarin's Q4 2023 financials: Revenues at $74.71 million, beating consensus. US net product revenue is $64.9 million, down Y/Y. CEO Patrick Holt shares operational progress, including European market...

Via Benzinga

Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

February 29, 2024

From Amarin Corporation plc

Via GlobeNewswire

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 29, 2024

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter financial results.

Via Benzinga

Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024

February 15, 2024

From Amarin Corporation plc

Via GlobeNewswire

Amarin Chairman & CEO Issue Letter to Shareholders

January 22, 2024

From Amarin Corporation plc

Via GlobeNewswire

Why TechTarget Shares Are Trading Higher By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 11, 2024

Shares of TechTarget, Inc. (NASDAQ: TTGT) rose sharply during Thursday’s session after the company announced a strategic combination with Informa Tech's digital businesses. TechTarget shares surged...

Via Benzinga

Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday ↗

January 11, 2024

U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply during Thursday’s session after the company issued a...

Via Benzinga

Topics Stocks

Crude Oil Falls 1%; Amarin Shares Spike Higher ↗

January 10, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 100 points on Wednesday. The Dow traded up 0.29% to 37,633.43 while the NASDAQ rose 0.72% to 14,965.31. The...

Via Benzinga

Topics Stocks

Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

January 10, 2024

Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

January 10, 2024

Via Benzinga

What's Going On With Amarin Stock? ↗

January 10, 2024

Amarin Corporation (NASDAQ: AMRN) shares are trading higher Wednesday after the company released a business update and announced a conditional s

Via Benzinga

Nasdaq Gains 50 Points; US Crude Inventories Rise Last Week ↗

January 10, 2024

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 50 points on Wednesday. The Dow traded up 0.17% to 37,588.15 while the NASDAQ rose 0.34% to 14,908.42. The S&P...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 10, 2024

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.